Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XBiotech Inc.XBIT · Entity 7044 | Director · 10% owner | June 20, 2024 | June 21, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XBiotech Inc.
Report date June 20, 2024 · Filed June 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.12 · Expires 2034-06-20 | Direct | 37,500 |
Reported balance
After 2024-06-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-20 · Grant · Acquired 37,500 · Balance 37,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 20, 2024 Filed Jun 21, 2024 14:16 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantDirector Stock Option · Derivative | 37,500 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0000950170-24-076084 · ownership.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2034-06-20 Read SEC document |
| June 23, 2023 Filed Jun 26, 2023 08:40 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantDirector Stock Option · Derivative | 25,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001209191-23-039570 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-23 Read SEC document |
| June 22, 2022 Filed Jun 27, 2022 18:00 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $5.89 | $0.00 |
DisclosureSEC source: 0001209191-22-039516 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-22 Read SEC document |
| December 16, 2021 Filed Jan 13, 2022 12:18 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 250,000 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003158 · doc4.xml · derivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 250,000 shares Expires 2021-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2021 Filed Jan 13, 2022 12:18 UTC | XBiotech Inc. XBIT · Entity 7044 | Tax withholdingCommon Stock | 213,493 | $11.71 | $2,500,003.03 |
DisclosureSEC source: 0001209191-22-003158 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,597,471 F1 · kind: Represents a "net exercise" of outstanding stock options. The reporting person received 36,507 shares of common stock on net exercise of option to purchase 250,000 shares of common stock. The Company withheld 213,493 shares of common stock underlying the option for payment of the exercise price using the closing stock price on December 16, 2021 of $11.71, pursuant to the terms of the 2005 Equity Incentive Plan. Read SEC document |
| December 16, 2021 Filed Jan 13, 2022 12:18 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 250,000 | $10.00 | $2,500,000.00 |
DisclosureSEC source: 0001209191-22-003158 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,810,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 10:45 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $16.21 | $0.00 |
DisclosureSEC source: 0001209191-21-042911 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-06-22 Read SEC document |
| November 19, 2020 Filed Nov 20, 2020 12:47 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 375,000 | $18.30 | $6,862,500.00 |
DisclosureSEC source: 0001209191-20-059611 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560,964 Read SEC document |
| August 27, 2020 Filed Sep 1, 2020 16:04 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $18.25 | $0.00 |
DisclosureSEC source: 0001209191-20-048898 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2030-08-27 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 15,214 | $30.00 | $456,420.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 32,524 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 31,870 | $30.00 | $956,100.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Foundation Disclosed balance after: 68,130 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 3,665 | $30.00 | $109,950.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 7,835 Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 16:44 UTC | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 1,401,856 | $30.00 | $42,055,680.00 |
DisclosureSEC source: 0001209191-20-009263 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,996,744 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 15,874 | $30.00 | $476,220.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 31,864 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 33,252 | $30.00 | $997,560.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Foundation Disclosed balance after: 66,748 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 3,825 | $30.00 | $114,750.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 7,676 Read SEC document |
| February 12, 2020 Filed Mar 19, 2020 13:34 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 1,462,636 | $30.00 | $43,879,080.00 |
DisclosureSEC source: 0001209191-20-020221 · doc4a.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935,964 Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 46,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · derivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,199,500 Underlying: Common Stock · 46,000 shares Expires 2020-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 77,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · derivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245,500 Underlying: Common Stock · 77,000 shares Expires 2020-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 16:19 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 123,000 | $3.75 | $461,250.00 |
DisclosureSEC source: 0001209191-20-002718 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,706,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 4, 2019 15:29 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionStock Option · Derivative | 185,000 | $0.00 Strike: $3.75 | $0.00 |
DisclosureSEC source: 0001209191-19-059014 · doc4.xml · derivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 185,000 shares Expires 2019-11-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 4, 2019 15:29 UTC | XBiotech Inc. XBIT · Entity 7044 | Exercise / conversionCommon Stock | 185,000 | $3.75 | $693,750.00 |
DisclosureSEC source: 0001209191-19-059014 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 6, 2018 16:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 7,159 | $3.69 | $26,396.66 |
DisclosureSEC source: 0001209191-18-049834 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,880,421 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6 to $3.89, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 15:33 UTC | XBiotech Inc. XBIT · Entity 7044 | GrantStock Option · Derivative | 25,000 | $0.00 Strike: $7.45 | $0.00 |
DisclosureSEC source: 0001209191-19-039647 · doc4.xml · derivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-06-27 Read SEC document |
| December 27, 2018 Filed Dec 28, 2018 16:17 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 1,364 | $4.92 | $6,705.83 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 32,702 Read SEC document |
| December 27, 2018 Filed Mar 4, 2019 15:40 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 1,364 | $4.92 | $6,705.83 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 6 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 47,738 Read SEC document |
| December 26, 2018 Filed Dec 28, 2018 16:17 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 3,600 | $5.00 | $17,996.04 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 31,338 Read SEC document |
| December 26, 2018 Filed Mar 4, 2019 15:40 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 18,636 | $5.07 | $94,566.52 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 46,374 Read SEC document |
| December 24, 2018 Filed Dec 28, 2018 16:17 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 24,838 | $5.88 | $146,097.12 |
DisclosureSEC source: 0001209191-18-064318 · doc4.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 27,738 Read SEC document |
| December 24, 2018 Filed Mar 4, 2019 15:40 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 24,838 | $5.88 | $146,097.12 |
DisclosureSEC source: 0001209191-19-015475 · doc4a.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 27,738 Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 16:50 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 700 | $3.75 | $2,625.00 |
DisclosureSEC source: 0001209191-18-058294 · doc4.xml · nonDerivative · entry 5 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 2,900 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 16:50 UTC | XBiotech Inc. XBIT · Entity 7044 | PurchaseCommon Stock | 2,200 | $3.74 | $8,217.00 |
DisclosureSEC source: 0001209191-18-058294 · doc4.xml · nonDerivative · entry 4 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 2,200 Read SEC document |
| October 04, 2018 Filed Oct 4, 2018 16:28 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 385,000 | $3.00 | $1,155,000.00 |
DisclosureSEC source: 0001209191-18-054253 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,398,600 Read SEC document |
| September 26, 2018 Filed Oct 1, 2018 13:18 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 17,634 | $3.05 | $53,797.81 |
DisclosureSEC source: 0001209191-18-052662 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,783,600 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.13, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 13, 2018 Filed Sep 18, 2018 12:37 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 7,909 | $3.10 | $24,548.75 |
DisclosureSEC source: 0001209191-18-051357 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,801,234 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.21, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 12, 2018 Filed Sep 18, 2018 12:37 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 41,675 | $3.06 | $127,546.34 |
DisclosureSEC source: 0001209191-18-051357 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,809,143 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.2, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 10, 2018 Filed Sep 11, 2018 17:25 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 23,369 | $3.22 | $75,334.65 |
DisclosureSEC source: 0001209191-18-050529 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,850,818 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 to $3.58, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 17:25 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 6,234 | $3.65 | $22,762.83 |
DisclosureSEC source: 0001209191-18-050529 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,874,187 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.54 to $3.755, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 05, 2018 Filed Sep 6, 2018 16:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 7,220 | $3.94 | $28,480.73 |
DisclosureSEC source: 0001209191-18-049834 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,887,580 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.85 to $4.01, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 16:35 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 3,800 | $3.99 | $15,179.10 |
DisclosureSEC source: 0001209191-18-049834 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,894,800 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.955 to $4.05, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 17:41 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 3,171 | $3.98 | $12,623.12 |
DisclosureSEC source: 0001209191-18-046477 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.9 to $4.02, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 17:41 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 6,638 | $4.00 | $26,523.46 |
DisclosureSEC source: 0001209191-18-046477 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 3,171 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.98 to $4.02, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 08, 2018 Filed Aug 8, 2018 16:38 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 4,000 | $4.01 | $16,024.00 |
DisclosureSEC source: 0001209191-18-045840 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 121,309 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.94 to $4.08, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 16:38 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 8,452 | $3.94 | $33,332.15 |
DisclosureSEC source: 0001209191-18-045840 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 125,309 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.05, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 16:38 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 3,340 | $3.99 | $13,327.60 |
DisclosureSEC source: 0001209191-18-045840 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 133,761 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $4.06, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 03, 2018 Filed Aug 3, 2018 16:27 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 23,900 | $3.96 | $94,689.41 |
DisclosureSEC source: 0001209191-18-045282 · doc4.xml · nonDerivative · entry 3 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 25,601 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.815 to $4.04, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 02, 2018 Filed Aug 3, 2018 16:27 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 30,461 | $3.92 | $119,528.96 |
DisclosureSEC source: 0001209191-18-045282 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 49,501 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.17, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:27 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 8,163 | $4.24 | $34,649.49 |
DisclosureSEC source: 0001209191-18-045282 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 79,962 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.41, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 31, 2018 Filed Aug 1, 2018 12:53 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 6,531 | $4.49 | $29,320.27 |
DisclosureSEC source: 0001209191-18-044669 · doc4.xml · nonDerivative · entry 2 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 88,125 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.41to $4.54, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 12:53 UTC | XBiotech Inc. XBIT · Entity 7044 | SaleCommon Stock | 5,344 | $4.41 | $23,542.46 |
DisclosureSEC source: 0001209191-18-044669 · doc4.xml · nonDerivative · entry 1 MCKENZIE W THORPE · CIK 0001211462 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 94,656 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.45, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.